Vaccine News and Research

Latest Vaccine News and Research

Researchers explore disease severity post-infection with SARS-CoV-2 Omicron in hematologic patients

A new study has studied the clinical outcome and spectrum in 61 patients infected with the SARS-CoV-2 Omicron variant.

29 Jun 2022

What you need to know about monkeypox

The World Health Organization said June 25 that monkeypox wasn't yet a public health emergency of international concern. More than 4,500 cases have been reported worldwide, with more than 300 in the U.S. And with public health officials unable to follow all chains of transmission, they're likely undercounting cases.

29 Jun 2022

Study finds Omicron variant could break through vaccine protection more effectively than the Delta variant

Researchers assessed the efficacy of vaccinations against SARS-CoV-2 Delta and Omicron variants of concern.

29 Jun 2022

Study explores antibody responses following three COVID vaccine doses in kidney transplant recipients

In a recent study posted to the medRxiv* pre-print server, Canadian researchers evaluated antibody responses in kidney transplant recipients (KTRs) before and one and three months after receiving the third dose of a messenger ribonucleic acid (mRNA)-based coronavirus disease 2019 (COVID-19) vaccine.

28 Jun 2022

Study compares protection induced by Delta breakthrough infections vs. COVID boosters against Omicron

Researchers compare the neutralizing ability of antibodies induced by Delta breakthrough infections and a third COVID-19 vaccine against Omicron.

28 Jun 2022

BNT162b2 COVID vaccine stimulates significant antibody response in lung cancer patients

In a recent article posted to the medRxiv* preprint server, scientists from Japan assessed the safety and immunogenicity of coronavirus disease 2019 (COVID-19) BNT162b2 vaccine among lung cancer patients under treatment.

28 Jun 2022

Acute COVID-19 and vaccination induce cross-reactive antibody responses in breast milk

IgA and IgG in human breast milk and blood were assessed for their activity against SARS-CoV-2 and SARS-CoV-1, as well as four other prevalent HCoVs.

28 Jun 2022

Potent antibody with a novel neutralization mechanism against SARS-CoV-2 variants

In a recent study posted to the bioRxiv* pre-print server, researchers in the United States described a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-neutralizing monoclonal antibody (mAb) SP1-77 that broadly neutralized its multiple variants of concern (VOCs).

28 Jun 2022

Digital revolution will provide faster, more personalized healthcare

People across the country will benefit from faster, more personalized healthcare, following a digital revolution to make the health and social care system fit for the 21st century.

28 Jun 2022

Phase 1 clinical trial of new influenza vaccine begins at NIH Clinical Center in Bethesda

A Phase 1 clinical trial of a novel influenza vaccine has begun inoculating healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland.

28 Jun 2022

The potential of DNA-based SARS-CoV-2 vaccine candidates

Researchers evaluated the immunogenicity of DNA-based candidate vaccines against SARS-CoV-2 in mice.

28 Jun 2022

In 1st year of pandemic, COVID vaccines saved 20M lives

In a recent study published in The Lancet journal, researchers at Imperial College London quantified the impact of the coronavirus disease 2019 (COVID-19) vaccination programs in 185 countries and territories between December 8, 2020, and December 8, 2021.

28 Jun 2022

Vaccine News and Research

Latest Vaccine News and Research

Researchers explore disease severity post-infection with SARS-CoV-2 Omicron in hematologic patients

What you need to know about monkeypox

Study finds Omicron variant could break through vaccine protection more effectively than the Delta variant

Study explores antibody responses following three COVID vaccine doses in kidney transplant recipients

Study compares protection induced by Delta breakthrough infections vs. COVID boosters against Omicron

BNT162b2 COVID vaccine stimulates significant antibody response in lung cancer patients

Acute COVID-19 and vaccination induce cross-reactive antibody responses in breast milk

Potent antibody with a novel neutralization mechanism against SARS-CoV-2 variants

Digital revolution will provide faster, more personalized healthcare

Phase 1 clinical trial of new influenza vaccine begins at NIH Clinical Center in Bethesda

The potential of DNA-based SARS-CoV-2 vaccine candidates

In 1st year of pandemic, COVID vaccines saved 20M lives

3rd COVID vaccine significantly reduced hospitalizations and deaths during Australia's 1st Omicron wave

Scientists assess potential of monkeypox transmission at mass gatherings

Researchers investigate clinical epidemiological impact of Omicron among hospitalized COVID-19 patients

Breakthrough infection with pre-Omicron variant induces cross-neutralizing activity against Omicron

Investigating PREVENT-19 trial findings of serological correlates of immune protection and risk against COVID-19

Study investigates the virological attributes of Omicron in a Syrian hamster model

Researchers determine public attitudes towards monkeypox infections

Model-based evidence shows SARS-CoV-2 vaccine boosters should be provided for those eligible ahead of winter

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in